High-Intensity Interval Training in the Early Subacute Stroke With a Semi-recumbent Bike
The Feasibility and Effects of Recumbent Cycling-based High-intensity Interval Training on Functional Performances, Cognitive Function, and Quality of Life in Early Subacute Stroke
1 other identifier
interventional
16
1 country
1
Brief Summary
Although High-intensity interval training (HIIT) exercise has emerged in recent years as a powerful time-efficient alternative to moderate-intensity continuous cardiovascular exercise training (MICT) to enhance neuroplasticity, motor, and cognitive functions, its feasibility remains to be determined early after stroke. Our study aims to investigate the feasibility of the HIIT program and its effects on functional abilities, cognitive function, and quality of life in early post-stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedFirst Posted
Study publicly available on registry
April 7, 2023
CompletedApril 7, 2023
April 1, 2023
4 months
February 15, 2023
April 6, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Feasibility aspects
The feasibility aspects, include recruitment rates (eligible population / consented population x 100), program adherence (attended sessions / total number of sessions x 100), and the safety (percentage of participants who will experience adverse events)
Up to 6 weeks
The change in the credibility of the treatment and the expectations of the participants
The treatment credibility and participant expectancy for improvement will be assessed with the Credibility and Expectancy Questionnaire (CEQ). The CEQ includes six items assessing a cognitively based credibility factor and an affectively based expectancy factor
Week 1 and Week 6
Secondary Outcomes (7)
Berg Balance Scale
Week 1 and Week 6
5-Repetition Sit-To-Stand test
Week 1 and Week 6
modified Rankin Scale
Week 1 and Week 6
6-min walk test
Week 1 and Week 6
10 m walk test
Week 1 and Week 6
- +2 more secondary outcomes
Study Arms (1)
HIIT-REC
EXPERIMENTALHigh-intensity interval training program on a recumbent cycle SOLE R92 (HIIT-REC)
Interventions
The experimental protocol will be preceded by 30 minutes of conventional physiotherapy followed by 15 min the rest period; then the HIIT-REC procedure will start at 4-min at 30% of the peak workload interspersed with 1-min at 70% of the peak workload at 50 rpm for weeks 1-2 and increased by approximately 5 minutes every two weeks as tolerated to reach 30 minutes from week 5 (4 to 6 repetitions). The training intensity will progress similarly by 5% peak workload two weeks as tolerated to reach 4-min at 40% peak workload interspersed with 1-min 80% peak workload from week-5
Eligibility Criteria
You may qualify if:
- first episode from an ischemic or hemorrhagic stroke confirmed by CT scan;
- muscular weakness of the leg on the hemiplegic side defined as NIHSS-Item 6 score between 1 and 3;
- Ashworth score of 0 or 1, indicating no spasticity or slight spasticity over the affected lower limb, respectively
- able to walk at least 5 meters independently with or without assistive devices and understand spoken instructions;
- living in Parakou or the surrounding area and wishing to undergo the program at the hospital.
You may not qualify if:
- Participants:
- unable to perform a graded exercise test, i.e., unable to maintain the designated pedaling rate;
- cardiovascular diseases (uncontrolled arrhythmias, decompensated heart failure or recent myocardial injury, arteriopathy);
- primary orthopedic conditions (fractures, active rheumatoid arthritis);
- other neurological diseases such as (Parkinson's disease and Alzheimer's disease).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hasselt Universitylead
- Université de Parakoucollaborator
Study Sites (1)
Faculty of Rehabilitation Sciences
Diepenbeek, 3590, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Oyene R Kossi, PhD
University of Parakou
- STUDY DIRECTOR
Thierry R Adoukonou, MD, PhD
University of Parakou
- PRINCIPAL INVESTIGATOR
Peter R Feys, PhD
Hasselt University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor of Rehabilitation/Exercise Physiology in Cardiometabolic Diseases
Study Record Dates
First Submitted
February 15, 2023
First Posted
April 7, 2023
Study Start
December 1, 2022
Primary Completion
March 31, 2023
Study Completion
March 31, 2023
Last Updated
April 7, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share
Data will be available to researchers upon request to the first author (ERA)